VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

BOPA 2018 | Limitations with AI programs for prescription screening

While artificial intelligence (AI) has revolutionized healthcare by minimizing the element of human error, thus improving efficiency, limitations do still exist. In this video, Bruce Burnett, MMedSci, of the University of Central Lancashire, Preston, UK, discusses the limitations of utilizing AI programs for prescription screening. This interview was recorded at the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter